Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-cv-03740/USCOURTS-cand-3_05-cv-03740-70/pdf.json

Nature of Suit Code: 890
Nature of Suit: Other Statutory Actions
Cause of Action: 28:1441 Petition for Removal

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

THE COUNTY OF SANTA CLARA, on behalf

of itself and all others similarly situated,

Plaintiffs,

 v.

ASTRA USA, INC., ASTRA ZENECA

PHARMACEUTICALS LP, EVENTS

PHARMACEUTICALS, INC., BAYER

CORPORATION, BRISTOL-MYERS SQUIBB

COMPANY, PFIZER, INC.,

SCHERING-PLOUGH CORPORATION TAP

PHARMACEUTICAL PRODUCTS, INC.,

ZENECCA, INC., ZLB BEHRING LLC,

SMITHKLINE BEECHAM CORPORATION,

SMITHKLINE BEECHAM CORPORATION

d/b/a GLAXO SMITHKLINE, WYETH, INC.,

WYETH PHARMACEUTICALS, INC.,

Defendants. /

No. C 05-03740 WHA

FURTHER ORDER

CLARIFYING THIRD

AMENDED CASE

MANAGEMENT ORDER RE

NON-PARTY SUBPOENAS

To be clear, the two subpoenas to non-party entities may cover more than two drugs so

that a subpoena to Kaiser, for example, can cover drugs produced by multiple defendants so long

as the overall subpoena is reasonable and non-burdensome. 

IT IS SO ORDERED.

Dated: August 5, 2010. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:05-cv-03740-WHA Document 683 Filed 08/05/10 Page 1 of 1